Edition:
United Kingdom

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

6.46USD
16 Oct 2018
Change (% chg)

$0.30 (+4.87%)
Prev Close
$6.16
Open
$6.22
Day's High
$6.48
Day's Low
$6.12
Volume
85,860
Avg. Vol
94,876
52-wk High
$8.26
52-wk Low
$3.30

Chart for

About

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $181.90
Shares Outstanding(Mil.): 29.06
Dividend: --
Yield (%): --

Financials

  OCUL.OQ Industry Sector
P/E (TTM): -- 32.38 32.69
EPS (TTM): -2.12 -- --
ROI: -76.17 14.01 14.32
ROE: -96.45 16.77 16.04

BRIEF-Ocular Therapeutix Reports Q1 Loss Per Share $0.40

* OCULAR THERAPEUTIX™ REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE

08 May 2018

Earnings vs. Estimates